In summary this study suggests an important role for IKKβ in E6-induced cellular abnormalities and that targeting IKKβ could be a potential therapeutic option for cervical cancer and, perhaps, for other HPV-related cancers for which there is currently no effective treatment. This evidence concerns the gene IKBKB and cervical cancer.